Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus
about
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation.Persistent molecular remission of refractory acute myeloid leukemia with inv(16)(p13.1q22) in an elderly patient induced by cytarabine ocfosfate hydrate.Treatment of older patients with acute myeloid leukemia (AML): revised Canadian consensus guidelines.
P2860
Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus
@en
type
label
Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus
@en
prefLabel
Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus
@en
P2093
P2860
P1476
Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus
@en
P2093
Andre C Schuh
Andrea K Kew
Brian Leber
Irwindeep Sandhu
Jeannine Kassis
John Ashkenas
John M Storring
Joseph M Brandwein
Michelle Geddes
Mitchell Sabloff
P2860
P304
P577
2013-05-05T00:00:00Z